Engineering services company L&T Technology Services Limited (NSE: LTTS) announced on Monday that it has partnered with AI computing company NVIDIA to unveil Gen AI and advanced software-defined architecture for medical devices, focusing on endoscopy. The collaborative effort aims to address industry challenges related to custom hardware components, enhancing image quality and scalability for medical applications.
The scalable platform integrates a comprehensive image processing pipeline, incorporating noise reduction, edge and contrast enhancement, texture and color enhancement and speckle correction. Unique features include AI/ML models for polyp detection during colonoscopies.
Leveraging NVIDIA Holoscan and NVIDIA IGX Orin platforms, the architecture ensures low-latency data transfer, superior image processing and scalability for multiple AI-enabled applications, enhancing visualisation and decision-making support.
L&T Technology Services, a subsidiary of Larsen & Toubro Limited, specializes in Engineering and R&D services, serving Fortune 500 and top ER&D companies globally across various industries. With over 23,800 employees and a vast global presence, the collaboration emphasizes cutting-edge advancements in medical imaging technology.
SHL Telemedicine introduces SmartHeart direct-to-consumer membership plan
Broncus Hangzhou signs Equity Transfer Agreement with Hangzhou Jingliang shareholders
Bracco signs long-term partnership with ulrich GmbH
L&T Technology Services plans to revolutionise medical imaging in collaboration with NVIDIA
Eli Lilly to build new high-tech manufacturing site in Germany
Teva Pharmaceuticals secures FDA approval for generic Forteo (teriparatide injection)
Zymo Research's SafeCollect Saliva Collection Kit receives US FDA approval
Kanabo Group extends contract with major UK retailer
Biodesix enhances Nodify Lung testing with Tasso+ blood draw method
Byotrol unveils PROCESSUS instrument decontamination system
Integrum plans FDA PMA submission for OPRA in transhumeral amputations
Telix and Mauna Kea Technologies expand collaboration in urologic oncology surgery
Egetis secures exclusive licence agreement with Fujimoto for Emcitate development in Japan
KDx Diagnostics enters into strategic collaborations with leading distributors in Europe